Depo-Provera (medroxyprogesterone acetate) is a commonly used birth control drug dating back to the 1950s. Despite the drug’s popularity, Depo-Provera has been repeatedly linked to the risk of developing intracranial meningiomas, otherwise known as brain tumors. In fact, a recent study published in the March 2024 British Medical Journal found that long-term use of the Depo-Provera contraceptive increased the risk of meningiomas by five times.
Symptoms of meningiomas can include persistent headaches, vision problems, memory loss, and severe neurological issues, though typically the growth of these meningiomas is asymptomatic. Nonetheless, if symptoms are present, they can be mistaken for other problems and, as a result, misdiagnosed. Unfortunately, it is not uncommon that a correct diagnosis occurs only after the tumors have grown large enough to affect nearby structures. Many affected women have undergone brain surgery or radiation, and still face ongoing medical challenges like epilepsy, motor disfunction, cognitive impairments, persistent headaches, depression, anxiety, and overall decline in their quality of life and independent functioning.
We believe that Pfizer’s failure to adequately warn consumers about these risks makes them liable for the health complications that are becoming increasingly common in women across the United States. In Europe, similar progestogens have already been restricted or removed from the market.
If you received at least 4 consecutive injections of Depo-Provera (or an authorized generic), or you were diagnosed with meningioma or a similar brain tumor after using the drug, please contact us today at (864) 582-5118 to learn more about your legal options and how we can help you seek justice.